| Secondary |
| Drug Use For Unknown Indication |
59.2% |
| Product Used For Unknown Indication |
25.3% |
| Drug Abuse |
3.7% |
| Suicide Attempt |
2.2% |
| Drug Abuser |
1.5% |
| Completed Suicide |
1.0% |
| Pain |
1.0% |
| Acute Lymphocytic Leukaemia |
0.7% |
| Drug Dependence |
0.7% |
| Status Epilepticus |
0.7% |
| Anxiety |
0.5% |
| Major Depression |
0.5% |
| Maternal Exposure Timing Unspecified |
0.5% |
| Substance Abuse |
0.5% |
| Foetal Exposure During Pregnancy |
0.4% |
| Depression |
0.4% |
| Dystonia |
0.3% |
| Hypersensitivity |
0.3% |
| Renal Cell Carcinoma |
0.3% |
| Substance Use |
0.3% |
|
| Completed Suicide |
26.6% |
| Respiratory Arrest |
15.9% |
| Death |
9.5% |
| Poisoning |
8.3% |
| Cardio-respiratory Arrest |
6.4% |
| Drug Abuse |
5.0% |
| Suicide Attempt |
4.5% |
| Vomiting |
3.1% |
| Drug Toxicity |
2.6% |
| Substance Abuse |
2.6% |
| Intentional Drug Misuse |
2.1% |
| Overdose |
1.9% |
| Rhabdomyolysis |
1.9% |
| Toxicity To Various Agents |
1.9% |
| Poisoning Deliberate |
1.4% |
| Premature Baby |
1.4% |
| Status Epilepticus |
1.4% |
| Renal Failure Acute |
1.2% |
| Unresponsive To Stimuli |
1.2% |
| Multiple Drug Overdose |
1.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.3% |
| Infantile Spasms |
13.9% |
| Drug Use For Unknown Indication |
9.3% |
| Pain |
5.9% |
| Depression |
5.2% |
| Hypertension |
4.3% |
| Schizophrenia |
3.8% |
| Bipolar Disorder |
2.9% |
| Psychotic Disorder |
2.9% |
| Sedation |
2.9% |
| Ill-defined Disorder |
2.7% |
| Dysthymic Disorder |
2.5% |
| Mania |
2.0% |
| Agitation |
1.8% |
| Anxiety |
1.8% |
| Back Pain |
1.6% |
| Smoking Cessation Therapy |
1.6% |
| Insomnia |
1.4% |
| Bone Marrow Conditioning Regimen |
1.3% |
| Borderline Personality Disorder |
1.3% |
|
| Vomiting |
12.5% |
| Overdose |
9.6% |
| Drug Ineffective |
8.7% |
| Venoocclusive Liver Disease |
6.7% |
| Weight Increased |
6.7% |
| Completed Suicide |
5.8% |
| Suicide Attempt |
5.8% |
| Epilepsy |
3.8% |
| Insomnia |
3.8% |
| Sedation |
3.8% |
| Somnolence |
3.8% |
| Transient Ischaemic Attack |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Withdrawal Syndrome |
3.8% |
| Atonic Seizures |
2.9% |
| Blood Creatine Phosphokinase Increased |
2.9% |
| Confusional State |
2.9% |
| Death |
2.9% |
| Drug Toxicity |
2.9% |
| Drug Withdrawal Syndrome Neonatal |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
33.3% |
| Psychotic Disorder |
33.3% |
| Epilepsy |
16.7% |
| Thrombosis Prophylaxis |
16.7% |
|
| Drug Interaction |
50.0% |
| Respiratory Depression |
25.0% |
| Somnolence |
25.0% |
|
